Email [email protected] Dissertation KMT2C directs estrogen receptor activity in normal and transformed mammary cells (2017) Mentor Sarat Chandarlapaty, MD, PhD Start Year 2012 End Year 2017 Education The College of New Jersey Fellowships Geoffrey Beene Graduate Student Fellowship (2013-2014) Publications Gala K, Li Q, Sinha A, Razavi P, Dorso M, Sanchez-Vega F, Chung YR, Hendrickson R, Hsieh J, Berger M, Schultz N, Pastore A, Abdel-Wahab O, Chandarlapaty S. (2018) KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function. Oncogene. Gala, K. and Chandarlapaty, S. (2014) Molecular pathways: HER3 targeted therapy. Clin Cancer Res, 20, 1410-1416. PMCID: PMC3977203. Toy, W., Shen, Y., Won, H., Green, B., Sakr, R., Will, M., Li, Z., Gala, K., Fanning, S., King, T., Hudis, C., Chen, D., Taran, T., Hortobagyi, G., Greene, G., Berger, M., Baselga, J., and Chandarlapaty, S. (2013) ESR1 ligand-binding domain mutations in hormone- resistant breast cancer. Nat Genet, 45, 1439-1445. PMCID: PMC3903423. Scaglione BJ, Salerno E, Gala K, Pan M, Langer JA, Mostowski HS, Bauer S, Marti G, Li Y, Tsiagbe VK, Raveche ES. (2009) Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice. J Autoimmun., 32, 14-23.
